Subscribe to Newsletter
Discovery & Development Analytical Science

New Workflow Optimized for Drug Metabolite Identification by Using Tribrid Mass Spectrometry and Advanced Acquisition Methodology

sponsored by Thermo Fisher Scientific

A new strategy using real-time background subtraction data acquisition on a tribrid Quadrupole-IonTrap-Orbitrap HRMS system is developed for in-vitro and in-vivo characterization of drug metabolites. It enables the possibility of collecting comprehensive MS full-scan and MSn scan spectra of the metabolites of interest without prior knowledge and prediction of metabolic pathways. Advanced post-acquisition analysis tools are readily utilized for in-depth data mining and structural elucidation.

Learning Objectives of Webinar

  1. Learn the cutting-edge technology of the tribrid mass spectrometry.
  2. Understand the new concept of advanced data-acquisition strategy.
  3. Learn the application on characterization of drug metabolites.

View on demand

Visit our Webinar Hub

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine